rosiglitazone has been researched along with bay 11-7082 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Azelmat, J; Barbeau, X; Carpentier, C; Grenier, D; Lagüe, P; Vaillancourt, K; Voyer, N | 1 |
| Cao, H; Cheng, YN; Dong, X; Dong, YN; Guo, XL; Sun, R; Wu, Y; Yang, KM; Yu, LG | 1 |
3 other study(ies) available for rosiglitazone and bay 11-7082
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Depsides; Dose-Response Relationship, Drug; Humans; Lactones; Lichens; Lipopolysaccharides; Macrophages; Molecular Docking Simulation; Molecular Structure; NF-kappa B; PPAR gamma; Salicylates; Signal Transduction; Structure-Activity Relationship; U937 Cells | 2018 |
Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.
Topics: Adenoviridae; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Cell Movement; Cell Proliferation; Focal Adhesion Kinase 1; Gene Expression Regulation; Losartan; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rosiglitazone; Signal Transduction; Sulfones; Thiazolidinediones; Tissue Culture Techniques; Transduction, Genetic; Vasodilator Agents | 2013 |